The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Open Offer

24 Jul 2017 07:00

RNS Number : 8230L
Proxama PLC
24 July 2017
 

24 July 2017

Proxama Plc

("Proxama" or the "Company")

Result of Open Offer

Result of Open Offer

On 30 June 2017, Proxama (AIM:PROX) announced details of a Placing and Open Offer to raise a minimum of £3.1 million through the issue of up to 13,652,877,197 New Ordinary Shares. The Open Offer closed for acceptances at 11.00 a.m. on 21 July 2017.

The Company received valid acceptances in respect of 4,299,389,893 Open Offer Shares and 870,359,239 shares under the Excess Application Facility. The total number of new shares under the Open Offer amounted to 5,169,749,132 new Ordinary Shares which is approximately 37.9 per cent. of the new Shares available so that the Company has raised gross proceeds of approximately £1.55 million through the Open Offer. In addition to this, certain placees have subscribed for an additional 166,666,667 of General Placing Shares, amounting to £50,000.

The gross proceeds of the Placing and Open Offer comes to approximately £3.1 million. Therefore, the minimum amount required in order for the Open Offer to be completed has been successfully reached.

As a result, the Company is now in a position to settle its £2.5 million revolving credit facility with Barclays and its loan note with White Angle. Proxama will now continue its transition to a location intelligence business, using its mobile location data to scale existing data and audience products and launch new attribution and verification products.

The Placing and Open Offer remain conditional, inter alia, upon the Resolutions being passed at the General Meeting to be held at 9.15 a.m. on 24 July 2017 and Admission. Proxama expects to announce the results of the General Meeting as soon as practicable on 24 July 2017 after the meeting concludes.

Subject to the passing of the Resolutions at the General Meeting, it is expected that admission of the 181,800,000 VCT Placing Shares and 185,701,733 EIS Open Offer Shares will become effective at 08:00 A.M. on 25 July 2017 ("First Admission"). The Circular published by the Company on 30 June 2017 stated that 166,666,666 EIS Placing Shares would be admitted on 25 July 2017. The placees in respect of these shares have requested that they receive General Placing Shares instead, and this number has therefore been included in the General Placing Shares figure below and no EIS Placing Shares will be issued.

Admission of the 1,000,000,000 Conversion Shares, 4,984,866,667 General Placing Shares and 4,984,047,399 Open Offer Shares to be admitted to trading on AIM is expected to become effective at 08:00 A.M. on 26 July 2017 ("Second Admission").

Barclays Warrants

As announced on 30 June 2017, having raised the minimum of £3.1 million under the Fundraising, Barclays has irrevocably agreed to the settlement of the Barclays Facility and will receive from the Company a cash payment of £375,000 and Barclays Warrants of 5,863,021,931.

Darwin Warrants

As announced on 30 June 2017, pursuant to the Darwin Warrant Instrument and as a consequence of the Fundraising and the issue of the Barclays Warrants, the exercise price of the Darwin Warrants shall be revised downwards to £0.001692 and the number of Darwin Warrants shall increase to 558,352,249 representing approximately 4.1% of the Enlarged Share Capital, in each case effective from Admission.

Unless otherwise defined in this announcement, defined terms used have the meaning given to them in the Circular posted to Shareholders on 30 June 2017.

Proxama's Group CEO, John Kennedy, said:

"I would like to thank our shareholders for supporting us with the funds we need to settle our debt arrangements, and accelerate our transition toward mobile location and intelligence data.

In recent weeks, we have significantly increased our access to audience data. The larger the mobile consumer audience that we have access to, the more data the Company can collect, the more value our platform can add, and therefore the more that we can charge and sell in order to grow revenues.

I am excited for the future direction of this business, and look forward to rewarding our shareholders for their support."

 

The announcement contains information which, prior to its disclosure, was inside information for the purposes of the Market Abuse Regulation.

 

Enquiries:

Proxama PLC

John Kennedy

Via Redleaf

Peel Hunt LLP(Nominated Adviser and Broker)

Richard Kauffer/Euan Brown

020 7418 8900

Redleaf Communications

Charlie Geller/Elise Palmer/Sam Modlin

020 7382 4769

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIUOOARBNABUUR
Date   Source Headline
16th Feb 202412:30 pmRNSResult of General Meeting
6th Feb 202410:55 amRNSHolding(s) in Company
30th Jan 20248:00 amRNSSchedule One - Location Sciences Group Plc
30th Jan 20247:30 amRNSRestoration - Location Sciences Group PLC
30th Jan 20247:00 amRNSAcquisition and Publication of Admission Document
25th Jan 20247:00 amRNSLoan Facility and Holding in Company
20th Dec 20237:00 amRNSFurther update on proposed acquisition of Sorted
6th Oct 20237:00 amRNSUpdate on proposed acquisition of Sorted
14th Sep 20237:00 amRNSHalf-year Report
28th Jul 20231:22 pmRNSResult of AGM
25th Jul 20237:00 amRNSHolding(s) in Company
28th Jun 20237:30 amRNSSuspension - Location Sciences Group plc
28th Jun 20237:00 amRNSLoan Agreement, Proposed Acquisition & Suspension
26th Jun 20237:00 amRNSAnnual Financial Report
11th Apr 20234:56 pmRNSHolding(s) in Company
31st Mar 202311:50 amRNSHolding(s) in Company
27th Mar 20237:00 amRNSHolding(s) in Company
22nd Mar 20233:47 pmRNSHolding(s) in Company
22nd Mar 20231:40 pmRNSHolding(s) in Company
22nd Mar 20239:05 amRNSSecond Price Monitoring Extn
22nd Mar 20239:00 amRNSPrice Monitoring Extension
15th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Sep 20227:00 amRNSHalf-year Report
30th Jun 202211:56 amRNSResult of AGM
6th Jun 20227:00 amRNSNotice of Annual General Meeting
1st Jun 20222:12 pmRNSDirector/PDMR Shareholding
1st Jun 20221:25 pmRNSDirector/PDMR Shareholding
1st Jun 20227:00 amRNSBoard and strategic update
5th Apr 202211:05 amRNSSecond Price Monitoring Extn
5th Apr 202211:00 amRNSPrice Monitoring Extension
30th Mar 20227:00 amRNSAnnual Financial Report
1st Feb 20227:00 amRNSFurther re Sale of Insights dashboard
24th Jan 202211:05 amRNSSecond Price Monitoring Extn
24th Jan 202211:01 amRNSPrice Monitoring Extension
22nd Oct 20218:05 amRNSSale of Insights dashboard
27th Sep 202112:09 pmRNSHalf-year Report
21st Jun 20211:27 pmRNSBusiness Review update and proposed Board changes
21st Jun 202111:28 amRNSHolding(s) in Company
18th Jun 202110:55 amRNSResult of AGM
11th Jun 202110:34 amRNSHolding(s) in Company
8th Jun 202111:54 amRNSHolding(s) in Company
1st Jun 20219:06 amRNSSecond Price Monitoring Extn
1st Jun 20219:00 amRNSPrice Monitoring Extension
28th May 20215:00 pmRNSTotal Voting Rights
28th May 20212:11 pmRNSHolding(s) in Company
27th May 20213:33 pmRNSTR-1 Notification of major holdings
25th May 20218:05 amRNSNotice of AGM
25th May 20218:01 amRNSBoard changes and appointment of Joint Broker
21st May 202111:14 amRNSGM Result, Issue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.